含羞草社区

?
?
?
?
Home Tags Posts tagged with "Yisheng Biopharma"

Tag: Yisheng Biopharma

Deal digest

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Cofoe Medical’s HKEX listing

Firms act on medtech maker Cofoe Medical’s HKD1.06bn IPO

RPC brings in Clyde & Co legal director as Singapore partner

RPC brings in Clyde & Co legal director as Singapore partner

Gilbert + Tobin Advises CDC Data Centres On USD2.75 Billion Fundraise

Gilbert + Tobin steers CDC’s USD2.75bn fundraise, debt reforms

Firms act on landmark USD300m solar financing in the Philippines

Viernam Law Firm Awards 2026

Vietnam Law Firm Awards

Asia Business Law Journal reveals the country’s top law firms

Force Majeure Contract Drafting

Updating force majeure clauses for India-Japan contracts

By Krishna Vijay Singh and Muneeb Rashid Malik, Kochhar & Co

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW
Follow 含羞草社区
Law firms Awards Events Legal jobs ? Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 含羞草社区. All rights reserved.

Follow us on LinkedIn